July 8 (Reuters) - Chr Hansen Holding A/S CHRH.CO :
* REG-CHR. HANSEN HOLDING A/S INTERIM REPORT Q3 2020/21
* REG-CHR. HANSEN HOLDING A/S INTERIM REPORT Q3 2020/21
* CHR. HANSEN - Q3 REVENUE EUR 280.6 MILLION VERSUS COMPANY COMPILED CONSENSUS OF EUR 281
MILLION
* CHR. HANSEN - OUTLOOK FOR 2020/21 ORGANIC REVENUE GROWTH 6-8%
* CHR. HANSEN - Q3 EBIT EX-ITEMS EUR 82.4 MILLION VERSUS COMPANY COMPILED CONSENSUS OF EUR
78
MILLION
* CHR. HANSEN - OUTLOOK 2020/21: EBIT MARGIN BEFORE SPECIAL ITEMS 27-28%
* CHR. HANSEN - OUTLOOK 2020/21: FREE CASH FLOW BEFORE SPECIAL ITEMS, ACQUISITIONS AND
DIVESTMENTS
EUR 140-160 MILLION
* CHR. HANSEN - Q3 PROFIT FROM CONTINUING OPERATIONS EUR 49.5 MILLION VERSUS COMPANY
COMPILED
CONSENSUS OF EUR 53 MILLION
* CHR. HANSEN - Q3 ORGANIC GROWTH IMPACTED BY REDUCED CONTRIBUTION FROM EUR-BASED PRICING
COMPARED TO H1
* CHR. HANSEN - Q3 ORGANIC GROWTH IMPACTED BY HIGHER COMPARABLE, AS Q3 LAST YEAR WAS
POSITIVELY
IMPACTED BY COVID-19 RELATED CUSTOMER INVENTORY BUILD-UP
* CHR. HANSEN - THE OVERALL MARKET FOR HUMAN HEALTH IS ESTIMATED TO HAVE GROWN BY 3-5%
DURING THE
FIRST NINE MONTHS OF 2020/21
* CHR. HANSEN - ACCORDING TO THE COMPANY’S OWN ESTIMATES, THE END MARKETS FOR FERMENTED MILK
DECLINED GLOBALLY IN THE FIRST NINE MONTHS OF 2020/21
* CHR. HANSEN - THE MARKET FOR MICROBIAL-BASED SOLUTIONS FOR ANIMALS DEVELOPED FAVORABLY
DURING
THE FIRST NINE MONTHS OF 2020/21,
* CHR. HANSEN - OVERALL OUTLOOK FOR HUMAN HEALTH REMAINS POSITIVE BUT CHANGED MIX BETWEEN
ORGANIC/ACQUISITION DRIVEN SALES WHICH WILL KEEP GROUP ORGANIC GROWTH BELOW ORIGINAL
EXPECTATIONS IN Q4
* CHR. HANSEN - PROFIT FOR Q3 OF EUR 682 MILLION WAS POSITIVELY IMPACTED BY RECOGNIZED GAIN
FROM
THE DIVESTMENT OF NATURAL COLORS OF EUR 636 MILLION
Source text for Eikon: ID:nGNE660hRq
Further company coverage: CHRH.CO
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))